
Merck agrees to settle NuvaRing cases for $100 million
The drug company Merck will pay $100 million to resolve lawsuits of women involving the NuvaRing contraceptive. NuvaRing may well put woman at a greater risk of blood clots, and stroke than other birth control methods. As an attorney who handles defective and dangerous product cases,the evidence in